Alvotech ALVO
5.75
(0.13)
(2.21%)
as of 25 Sep
- Market cap
- $2.3B
- P/E
- 0.0×
Follow ALVO
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 0.00% | 101.38% | 0.00% | 0.00% |
+8 more TTM periods Free account |
|
| 0.00% | (22.23%) | 0.00% | 0.00% | ||
ROIC |
0.00% | (8.07%) | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | (53.26%) | 0.00% | 0.00% | |
Average Days of Receivables |
0.00 | 60.34 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | (0.54) | — | 0.00 | |
Free Cash Flow |
(211.69) | (157.95) | — | (274.92) | |
Capital Expenditures |
(199.93) | (178.53) | — | (158.28) | |
Piotroski F-Score |
— | 7.00 | — | — | |
| Other line items | |||||
Cash ROIC |
(0.94%) | 1.89% | 0.00% | (11.78%) | |
Accounts Receivable Turnover |
0.00 | 2.70 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 2.03 | 0.00 | 0.00 | |
Inventory Turnover |
0.00 | 0.91 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 212.60 | 0.00 | 0.00 | |
Days of Inventory on Hand |
0.00 | 495.34 | 0.00 | 0.00 | |
Tax Rate |
— | (0.12) | — | — | |
Research and Development Expense of Revenue |
— | 56.53% | — | — | |
Selling, General and Administrative Expense of Revenue |
— | 26.06% | — | — | |
Share Based Compensation of Revenue |
0.00% | 4.07% | — | 0.00% | |
Interest Coverage |
— | 0.00 | — | — | |
Operating CF/Net income |
0.00 | (0.07) | — | 0.00 | |
Depreciation/Fixed assets |
0.15 | 0.15 | 0.00 | 0.19 | |
Capex/Depreciation |
(3.51) | (3.25) | — | (2.34) | |
Revenue per Share |
— | 1.00 | — | — | |
Operating CF per Share |
0.00 | 0.07 | — | 0.00 | |
Capex per Share |
0.00 | (0.61) | — | 0.00 | |
Capex to Sales |
0.00 | 0.61 | — | 0.00 | |
Net Profit Margin |
— | (101.05%) | — | — |
Columns are period end dates